SLC4A11

Across TCGA pan-cancer cohorts, SLC4A11 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SLC4A11’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SLC4A11 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SLC4A11 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

HNSC and LSCC are the cancer types where SLC4A11 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC4A11 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	−0.521	.007	11	view →
LSCC	Male	II,III,IV	+0.875	<.001	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SLC4A11–HNSC

Open the HNSC breakdown →